Investigators at LA BioMed are pleased to be involved with the PELICAN Study – a research program designed to help improve the benefits of oxygen use among patients with COPD. The study is being conducted by the University of Illinois, Chicago, and is part of larger program called PCORI, (the Patient Centered Outcome Research Institute), which funds studies whose designs are influenced by patient input. LA BioMed investigators, who are members of PERF’s Board of Directors, are processing data from this study on adherence to oxygen therapy.
You’re eligible to participate in the PELICAN Study if you have COPD, are over 18, have a prescription for oxygen, and use oxygen 24 hours a day. As a participant, you’ll receive patient-friendly educational material developed by the COPD Foundation, which you can read at home at your own pace, and you’ll receive periodic phone calls over the three-month period of your participation. You will be compensated for your participation.
For more information on how you can “take flight” with PELICAN, call the PELICAN program at 1-844-627-5587.